Fiala

Peptide library › Heart & blood

Selepressin

In clinical trialsHeart & blood

Experimental vasopressin-like drug for septic shock that failed its main trial.

What people use it for

What Selepressin does in the body

Acts only on vasopressin's V1a receptor, aiming to raise blood pressure while causing less fluid build-up than vasopressin.

Strength of evidence

Limited: the large SEPSIS-ACT trial was stopped for futility, finding no benefit.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

Investigational. Not approved by the FDA.

How it's taken

Route: Drip into a vein (in trials)

How long it lasts (half-life): Short: minutes to hours

Keep track of Selepressin privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Selepressin in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Heart & blood